AI setting stage for Snowflake's growth in fiscal '27, say analysts

Q4 results beat estimates, while analysts noted that AI is setting the stage for durable growth in fiscal 2027 for the ...
The Caledonian-Record

Olezarsen sNDA accepted by the FDA for Priority Review for the treatment of severe ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for olezarsen ...